3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
2
Urinary Bladder Neoplasms
1
Rhabdoid Tumor
1
Recurrence
1
Prostatic Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Glioma
1
Diffuse Intrinsic Pontine Glioma
1
Brain Neoplasms
1
Interventions
Temozolomide
162
Radiosurgery
114
Radiotherapy
99
Bevacizumab
95
Magnetic Resonance Spectroscopy
64
Carboplatin
48
Etoposide
34
Surgical Procedures, Operative
33
Irinotecan
33
pembrolizumab
32
Nivolumab
32
Cyclophosphamide
32
Erlotinib Hydrochloride
31
Radiation
29
Carmustine
28
Cisplatin
25
Lomustine
24
Trastuzumab
23
Ipilimumab
23
Filgrastim
23
Vincristine
20
Mental Status and Dementia Tests
20
Aminolevulinic Acid
19
Topotecan
18
Pemetrexed
18
Capecitabine
18
Specimen Handling
17
Sorafenib
15
Radiotherapy, Intensity-Modulated
15
Imatinib Mesylate
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Brain Neoplasms
×
gallium maltolate
×
Clear all
NCT07331064
2026-01-09
GABRIEL
Medical College of Wisconsin
Phase 1
Not yet recruiting
15 enrolled